RECOVERS - Realigning Emotion and COgnition Via prEcision Regulation networkS
Part of paid clinical trials in Charleston, South Carolina.
- Sponsor
- Medical University of South Carolina
- Study ID
- NCT05977439
- Status
- Recruiting
Conditions
- Depression - Major Depressive Disorder
- Healthy
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Accepted
Interventions
- fMRI-EEG-TMS — DEVICEParticipants will undergo a magnetic resonance imaging (MRI) scan with combined electroencephalography (EEG), and single-pulse transcranial magnetic stimulation (TMS) while completing cognitive flexibility (CF) and emotion recognition (CR) tasks.
- fNIRS-EEG-TMS — DEVICEParticipants brain activity will be measured using functional near-infrared spectroscopy (fNIRS) with combined electroencephalography (EEG), and single-pulse transcranial magnetic stimulation (TMS) while completing cognitive flexibility (CF) and emotion recognition (CR) tasks.
- fNIRS-EEG-rTMS Interleaved with CBT — DEVICEParticipants brain activity will be measured using functional near-infrared spectroscopy (fNIRS) with combined electroencephalography (EEG), and repetitive transcranial magnetic stimulation (rTMS). rTMS will be delivered via a MagVenture MagPro100 and Cool-B65 coil. The investigators will use a standard resting motor threshold (rMT) determination to determine the TMS dose. Treatment will be delivered at 120% of the motor threshold. The accelerated paradigm will consist 6 session a day for 5-6 days. Each rTMS session will be separated by 30 minutes of Cognitive Behavioral Therapy (CBT). rTMS treatment will be delivered at an individualized left DLPFC target based on each participant's individualized scans from prior neuroimaging sessions.
Study Details
In this research study, the investigators are examining how brain activity (electrical and blood flow) changes during tests of emotional processing, attention and memory in the magnetic resonance imaging (MRI) scanner and outside the MRI using functional near-infrared spectroscopy (fNIRS). Investigators are also using non-invasive brain stimulation to probe different parts of the brain and measuring brain activity (electrical and blood flow). Study 1 This study includes healthy participants and researchers hope this will help us develop improved brain-based treatments for emotional difficulties like depression. Study 2 This study includes participants with depression and researchers hope this will help us develop improved brain-based treatments for emotional difficulties like depression.
Key Dates
- Start date
- Feb 1, 2024
- Status verified
- Aug 2025
- Primary completion
- Oct 1, 2027
- Completion
- Oct 1, 2028
Study Design
- Enrollment
- 30 participants (estimated)
Arms
- Arm: Healthy ParticipantsEndorse good health with no history of mental or physical illness or implanted metal
- Arm: Depressed ParticipantsEndorse current depression, identified via the Hamilton Depression Rating Scale (HAM-D scores ≥ 17), but no history of psychosis or mania, determined via the Quick Structured Clinical Interview for DSM-5 Disorders (SCID).
Primary Outcome Measure
Change in reaction time (RT) tasks - Incongruent Stimuli [ Time Frame: Day 1, Day 2, Day 3 ]
Central Contacts
- Lisa McTeague, PhD843-792-8274
- Jacob Eade, MS
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Medical Univeristy of South Carolina | Charleston | South Carolina | 29425 | Jacob Eade |
Find similar trials in Charleston, SC
Related Studies
- Safety, Parameterization, and Mechanism of Transcranial Focused UltrasoundNot Yet Recruiting · Medical University of South Carolina · Charleston, South Carolina
- tFUS Induced Transient Scotoma for Individual DosingRecruiting · Medical University of South Carolina · Charleston, South Carolina
- Combining rTMS & Aerobic Exercise to Treat Depression and Improve Post-Stroke WalkingRecruiting · Medical University of South Carolina · Durham, North Carolina
- BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their BabiesPHASE3 · Recruiting · Pfizer · Birmingham, Alabama